Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease

Insights

Chronic granulomatous disease (CGD) patients’ neutrophils can metabolize arachidonic acid to leukotrienes. This process is independent of the superoxide anion, suggesting CGD defects do not impact leukotriene production.

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by impaired function of phagocytes, particularly neutrophils.
  • Phagocytes play a crucial role in host defense through the generation of reactive oxygen species and the production of inflammatory mediators like leukotrienes.

Purpose of the Study:

  • To investigate the ability of polymorphonuclear leukocytes (PMNL) from CGD patients to metabolize arachidonic acid into lipoxygenase products, specifically leukotriene B4 (LTB4).
  • To determine if the impaired respiratory burst in CGD neutrophils affects arachidonic acid oxidation pathways.

Main Methods:

  • PMNL were isolated from two CGD patients and healthy controls.
  • Incubations with arachidonic acid and the calcium ionophore A23187 were performed.
  • Production of LTB4 and other hydroxy-eicosatetraenoic acids was analyzed.
  • PMNL chemiluminescence and generation of active oxygen species were assessed.

Main Results:

  • PMNL from CGD patients produced LTB4 and other lipoxygenase products at levels comparable to controls.
  • The production of these metabolites occurred even in the absence of detectable superoxide anion generation.
  • CGD leukocytes failed to generate active oxygen species in response to stimuli, confirming the disease phenotype.

Conclusions:

  • The ionophore-induced production of leukotrienes from arachidonic acid is dissociated from the leukocyte respiratory burst and superoxide anion generation.
  • The defect in chronic granulomatous disease does not appear to impair the ability of PMNL to oxygenate arachidonic acid to leukotrienes.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...